Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19

Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19

Common clinical features of patients with Coronavirus disease-2019 (COVID-19) vary from fever, to acute severe respiratory distress syndrome. Several laboratory parameters are reported as indicators of COVID-19 severity. We hereby describe the possible novel severity biomarkers for COVID-19, CD11b+C...

Full description

Bibliographic Details
Main Authors: Ricardo Wesley Alberca, Milena Mary de Souza Andrade, Anna Cláudia Calvielli Castelo Branco, Anna Julia Pietrobon, Nátalli Zanete Pereira, Iara Grigoletto Fernandes, Luana de Mendonça Oliveira, Franciane Mouradian Emidio Teixeira, Danielle Rosa Beserra, Emily Araujo de Oliveira, Sarah Cristina Gozzi-Silva, Yasmim Álefe Leuzzi Ramos, Cyro Alves de Brito, Marcelo Arnone, Raquel Leao Orfali, Valeria Aoki, Alberto Jose da Silva Duarte, Maria Notomi Sato
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Medicine
Subjects:
SARS-CoV-2
infection
COVID-19
biomarker
severity
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.580677/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2020.580677/full

Similar Items